Estimates Revisions Collegium Pharmaceutical, Inc.

Stocks

Market Closed - Nasdaq 04:00:00 16/09/2026 HKT			5-day change	1st Jan Change
21.84 ^USD	-4.25%		-6.55%	-52.83%

09-09	Leerink Partners Initiates Coverage on Collegium Pharmaceutical With Outperform Rating, $45 Price Target	MT
09-09	Truist Cuts Price Target on Collegium Pharmaceutical to $49 From $58, Keeps Buy Rating	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	COLLEGIUM PHARMACEUTICAL, INC.
	ELI LILLY AND COMPANY
	JOHNSON & JOHNSON
	ABBVIE INC.
	ROCHE HOLDING AG
	NOVARTIS AG
	ASTRAZENECA PLC
	AMGEN INC.
	NOVO NORDISK A/S
	GILEAD SCIENCES, INC.
	Average
	Weighted average by Cap.